{"id":332722,"date":"2021-06-28T02:07:19","date_gmt":"2021-06-28T07:37:19","guid":{"rendered":"http:\/\/tehelka.com\/?p=332722"},"modified":"2021-06-28T02:07:19","modified_gmt":"2021-06-28T07:37:19","slug":"adar-poonawala-assures-to-resolve-covishields-eu-travel-issues","status":"publish","type":"post","link":"https:\/\/tehelka.com\/adar-poonawala-assures-to-resolve-covishields-eu-travel-issues\/","title":{"rendered":"Adar Poonawala assures to resolve Covishield\u2019s EU travel issues"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-332723\" src=\"http:\/\/tehelka.com\/wp-content\/uploads\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla.jpg\" alt=\"\" width=\"1200\" height=\"900\" srcset=\"https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla.jpg 1200w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-300x225.jpg 300w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-768x576.jpg 768w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-1024x768.jpg 1024w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-80x60.jpg 80w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-265x198.jpg 265w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-696x522.jpg 696w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-1068x801.jpg 1068w, https:\/\/tehelka.com\/media\/2021\/06\/india-may-face-vax-crunch-for-2-3-months-poonawalla-560x420.jpg 560w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<p>Adar Poonawalla, CEO of Serum Institute tweeted Monday, reassure to resolve the issue of Covishield-vaccinated Indians face problems with travel to the European Union as per EU&#8217;s new &#8216;vaccine passport&#8217; scheme.<\/p>\n<p>He said the matter is being taken up at the highest levels, hoping to resolve this matter soon.<\/p>\n<p>&#8220;I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the E.U., I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,&#8221;he said in a tweet.<\/p>\n<p>Covishield, a Covid-19 vaccine manufactured by the Serum Institute of India hasn\u2019t been permitted by European Medicines Agency.<\/p>\n<p>According to the rules, the travelers who have taken the Covishield, manufactured by Pune-based SII won&#8217;t be eligible for the European Union &#8216;Green Pass&#8217;.<\/p>\n<p>So far, only 4 vaccines; Comirnaty (Pfizer), COVID-19 Vaccine Janssen, Spikevax and AstraZeneca&#8217;s Vaxzevria have been approved by the regulatory authority.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adar Poonawalla, CEO of Serum Institute tweeted Monday, reassure to resolve the issue of Covishield-vaccinated Indians face problems with travel to the European Union as per EU&#8217;s new &#8216;vaccine passport&#8217; scheme. He said the matter is being taken up at the highest levels, hoping to resolve this matter soon. &#8220;I realise that a lot of [&hellip;]<\/p>\n","protected":false},"author":59,"featured_media":332723,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[36],"tags":[13487,12750,13845,13995],"_links":{"self":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/332722"}],"collection":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/comments?post=332722"}],"version-history":[{"count":2,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/332722\/revisions"}],"predecessor-version":[{"id":332726,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/332722\/revisions\/332726"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/media\/332723"}],"wp:attachment":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/media?parent=332722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/categories?post=332722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/tags?post=332722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}